Improved methods of retroviral vector transduction and production for gene therapy.
about
Promotion of cell cycle progression by basic helix-loop-helix E2ADioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structureHematopoietic fingerprints: an expression database of stem cells and their progenyAssociation of SWAP-70 with the B cell antigen receptor complexEx vivo gene transfer in the years to come.Hematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsCentrifugal enhancement of hepatitis C virus infection of human hepatocytesPLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 proteinDissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transferThe effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.A serum-free Vero production platform for a chimeric virus vaccine candidateThe orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cellsDetermination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in miceExpression of IMP1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging.Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cellsHigh-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytesPolymeric PARACEST MRI contrast agents as potential reporters for gene therapy.Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin)Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trialsIncrease in the titer of lentiviral vectors expressing potassium channels by current blockade during viral vector productionLEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.Proteoglycans secreted by packaging cell lines inhibit retrovirus infectionRetroviral vector production in the National Gene Vector Laboratory at Indiana University.The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.E47 retroviral rescue of intrinsic B-cell defects in senescent mice.Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages.Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo.Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative diseaseViral vectors: from virology to transgene expressionImproved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.Downstream processing of cell culture-derived virus particles.New developments in lentiviral vector design, production and purification.Immediate-early MEK-1-dependent stabilization of rat smooth muscle cell cyclooxygenase-2 mRNA by Galpha(q)-coupled receptor signaling.Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells.Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery.Mobilization of full-length Semliki Forest virus replicon by retrovirus particles.Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection.
P2860
Q24291573-DC327EF8-D506-49A7-A4CB-4899441212EEQ24650888-18852F98-9463-499C-AB11-E1B62D6FA6EEQ24656674-B13939B6-CC84-4011-A3D7-57B91C0AF8BFQ24670204-8BF119CA-4CB1-45EE-B80E-3F2F55B5148EQ24805886-948F5882-42B3-4646-9BC8-E84F9AA0DCBFQ26859147-FEAE9184-91DB-44AF-8EAB-99F60FF20AA4Q27488754-0BFB34B5-2C28-4608-B254-D3E542C697B7Q28202849-D002731A-6AF2-41E7-8578-ED829A919A86Q28593279-23F22E8D-F5AF-46B9-A55C-1CD4EC174A71Q30452571-0C4FE70A-E1F1-4B08-94CF-A94946FD8C07Q30462034-A7E76302-AA0C-4173-B7A0-088F3C58F80AQ30498822-16F15348-953E-4EBE-BD79-FA211735379FQ30921356-3DF99F17-F1EB-4797-8067-22FB1F566A05Q33510153-414ECAD0-397C-4600-B9A2-20478955B647Q33786927-3DF27061-5E36-4102-B6D9-BE260AD7E761Q33787937-BAD1C21E-93B2-47B2-B748-D286AC8E81C3Q34003623-E807F099-F1D9-4DB4-8D39-48AD3C59BE8BQ34552409-73811132-ED30-46BE-88A2-3C5309732EB0Q35134095-FFD1E714-23AC-448E-AA56-3356BCB0BBF3Q35180417-781B200E-FA92-4CBF-976E-CECFBA3E6B7EQ35622018-56FF80C1-9309-4697-84A9-1310D395F8AFQ35808591-9145E021-8FA5-47D7-9831-DD5A09794853Q35869053-989E1BC2-C0FC-42EF-9314-EC98F6F1881BQ36288912-349497F8-1D47-45C4-BACC-72BD50CD7873Q36368162-1834F1E9-1887-454E-92FC-648FD6B87C30Q36455989-D39029CC-07F5-4018-A7A2-FC003078CD1EQ36463055-AF060A84-969C-4CC8-8F4B-C78627658CDAQ36568936-58DC8328-8388-4F6A-8FEB-3736EA479B90Q36843762-BE64330B-97F2-4F6F-BCA1-03B13772FA0EQ37262766-5372E9ED-FF32-4CC3-A6A3-9A5B8F678BC0Q37273028-7A4B26FE-F092-46D0-A8B4-7B534CF88B7FQ37383736-541DDBE3-B559-48BD-B6EA-69811AA209B6Q37944322-0E3D130B-53EC-4268-97E6-93273F9C0887Q38099382-DBD37F9B-C6FB-4676-9059-9F996AA2E346Q38312174-6DB55F21-E773-4D34-A853-BC9093266DAFQ38613503-92E4923C-72C3-4AF2-8026-8C57916F7967Q38709200-EAB86752-2819-4FF6-A9B3-0C23DF583A70Q38760486-132F672A-5F2A-4A60-8BB1-8C95E6030D9AQ39550466-F4848A67-ED92-4C30-9745-C00407B1C851Q39588222-3F343DA1-BB56-49C9-A4BC-2329B03DB5B2
P2860
Improved methods of retroviral vector transduction and production for gene therapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Improved methods of retroviral vector transduction and production for gene therapy.
@en
Improved methods of retroviral vector transduction and production for gene therapy.
@nl
type
label
Improved methods of retroviral vector transduction and production for gene therapy.
@en
Improved methods of retroviral vector transduction and production for gene therapy.
@nl
prefLabel
Improved methods of retroviral vector transduction and production for gene therapy.
@en
Improved methods of retroviral vector transduction and production for gene therapy.
@nl
P2093
P356
P1433
P1476
Improved methods of retroviral vector transduction and production for gene therapy.
@en
P2093
Anderson WF
McGarrity GJ
Newton PB 3rd
P356
10.1089/HUM.1994.5.1-19
P577
1994-01-01T00:00:00Z